Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors-Reference-Cited by-同舟云学术

Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors

Published:2021-01-04 Issue:5 Volume:26 Page:377-390
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:Nephrology

Author:

Scholtes Rosalie A.¹,Baar Michaël J. B.¹,Kok Megan D.¹,Bjornstad Petter²³,Cherney David Z. I.⁴,Joles Jaap A.⁵,Raalte Daniël H.¹⁶^ORCID

Affiliation:

1. Amsterdam Diabetes Center, Department of Internal Medicine, Academic Medical Center VU University Medical Center Amsterdam The Netherlands

2. Department of Pediatrics, Division of Endocrinology University of Colorado School of Medicine Aurora Colorado USA

3. Department of Medicine, Division of Nephrology University of Colorado School of Medicine Aurora Colorado USA

4. Department of Medicine and Department of Physiology, Division of Nephrology, University Health Network University of Toronto Toronto Ontario Canada

5. Department of Nephrology and Hypertension University Medical Center Utrecht The Netherlands

6. Department of Vascular Medicine, Academic Medical Center University of Amsterdam Amsterdam The Netherlands

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nep.13839

Reference131 articles.

1. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end‐stage renal disease in the United States;Collins AJ;Am J Kidney Dis,2012

2. Diabetic Kidney Disease

3. Pleiotropic effects of type 2 diabetes management strategies on renal risk factors

4. Diabetic Nephropathy: Diagnosis, Prevention, and Treatment

5. Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Insights into the Nephroprotective Potential of Lercanidipine;International Journal of Molecular Sciences;2023-09-13

2. Home Blood Pressure-based Guidance Did Not Increase Anti-albuminuric Effects on Diagnostic Provision of Microalbuminuria in School Workers: A Miyagi Karoshi Prevention Study;Internal Medicine;2023-04-15

3. Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure;ESC Heart Failure;2023-02-13

4. Favorable effect of renal denervation on elevated renal vascular resistance in patients with resistant hypertension and type 2 diabetes mellitus;Frontiers in Cardiovascular Medicine;2022-12-14

5. Kidney Hemodynamic Effects of Angiotensin Receptor Blockade, Sodium-Glucose Cotransporter-2 Inhibition Alone, and Their Combination: A Crossover Randomized Trial in People With Type 2 Diabetes;Circulation;2022-12-13